Valink Therapeutics
Entity

  • Valink Therapeutics

    Created in 2020


  • Up & running (A)
    Existing signals show a regular activity

  • Social networks

    3,788

  • Activities

    biotech deeptech

  • Technologies

    Synthetic Biology

  • Entity types

    Startup

  • Location

    Cambridge, MA 02142, USA

    Cambridge

    United States of America

  • Employees

    Scale: 11-50

    Estimated: 30

  • Engaged catalyst

    1
    0 0

  • Added in Motherbase

    9 months, 4 weeks ago
Description
  • Value proposition

    Making better ADCs

    Valink Therapeutics focusses on synergistic and non-obvious target combinations to create novel multivalent bispecific antibody-drug conjugates (bsADCs) that transform the treatment of solid tumors and other indications.

    Valink is a platform therapeutics company focussing on the discovery of bsADCs based out of Cambridge, MA and London, UK. The company is a VC-backed & Y Combinator (W21)-incubated spin-out of the University of Oxford, with over $20M total capital raised.

  • Valink Therapeutics |

    Valink is developing a series of novel therapeutics that are more effective at attacking tumours, while sparing healthy tissue.

    • https://www.valinktx.com/
Catalyst interactions
Catalyst Type Tweets Articles
Oxford University Innovation
Oxford University Innovation
Research, Investment Management (Auto)
Oxford University Innovation
Research, Investment Management (Auto) 		Other

18 Jan 2025


Social network dynamics
Similar entities
BETA
Last news
Show all articles